Assessing the impact of Transcranial Direct Current Stimulation (tDCS) over the dorsolateral prefrontal cortex on social communication in children and adolescents with Autism Spectrum Disorder (ASD). Volume 161, article 104958.
View publication (DOI)Transparent Methods and Evidence
Publications, Methods and Scientific Evidence
Neuromap™ is developed within an active clinical and research environment. This page distinguishes peer-reviewed publications, research methods, technical notes and work that has not yet undergone peer review.
Peer-reviewed publications
QEEG-Guided rTMS in Pediatric ASD with Contextual Evidence on Home-Based tDCS: Within-Cohort Reanalysis and Narrative Contextualization. Children, 12(11), 1453.
View publication (DOI)Mixed-Frequency rTMS Rapidly Modulates Multiscale EEG Biomarkers of Excitation-Inhibition Balance in Autism Spectrum Disorder: A Single-Case Report. Brain Sciences, 15(12), 1269.
View publication (DOI)How evidence is presented
- Publication status is stated accurately: peer reviewed, preprint, submitted, under review, conference abstract, technical note or unpublished.
- Every entry identifies the citation, persistent link, study design, sample, Neuromap™ role and relevant conflicts of interest.
- Case reports and observational findings are not presented as proof of general efficacy.
- Exploratory and post hoc findings are labelled and separated from prespecified analyses.
- Performance claims include the dataset, comparator, sample size, uncertainty and external-validation status.
- Research involving proprietary methods declares relevant ownership or employment interests.
Methods library
Acquisition compatibility
Montage, reference, sampling rate, duration, state, event markers, metadata and minimum usable-data considerations.
Signal-quality and QC methods
Recording completeness, channel integrity, artefact burden, data sufficiency, protocol deviations and exception handling.
Quantitative analysis domains
Spectral, frequency, regional-balance, connectivity, temporal, complexity, network and longitudinal methods.
Reference comparison
Reference-dataset eligibility, transformations, z-score interpretation, population limitations and permitted conclusions.
Longitudinal methods
Matched acquisition, version control, within-participant change, group trajectories, missing data and confounding variables.
AI and computational methods
Algorithm role, input requirements, output uncertainty, human oversight, change control and research-use limitations.
Validation and performance evidence
Only traceable evidence is published. A validation entry must state the intended use, dataset source, inclusion criteria, sample size, reference standard or comparator, analysis plan, missing-data handling, performance measures, confidence intervals, internal or external validation, known limitations and conflicts of interest. Internal benchmark observations are labelled as internal and are not presented as independent clinical validation.
Research governance and transparency
- Ethics and approval information for each relevant project.
- Participant consent or approved alternative basis.
- Data-protection and data-availability statement.
- Funding and sponsor involvement.
- Author contributions.
- Conflicts of interest and proprietary-method declarations.
- Corrections, retractions or material updates where applicable.
Scientific leadership
Neuromap™ was developed under the leadership of Dr Alptekin Aydın, specialist neuropsychologist and neuroscience researcher. ORCID: 0000-0002-9470-1953. Biographies, qualifications, affiliations and publication records displayed on the website are maintained against verified source information.
Evidence disclaimer
Scientific content on this website describes research methods, publications and available services. It must not be interpreted as evidence that every Neuromap™ output is clinically validated, diagnostically approved, a medical device function or suitable as a regulatory endpoint. Evidence from a specific population, method or study design must not be generalised beyond its support.
Frequently asked questions
Common questions about Neuromap™ publications and evidence.
Are all Neuromap™ analyses clinically validated?
No. The platform includes research and exploratory outputs. Validation status must be stated for the specific variable and intended use.
Are case reports evidence of efficacy?
Case reports can demonstrate feasibility and generate hypotheses, but they do not establish general efficacy.
Will submitted manuscripts be displayed as published research?
No. Status must be shown accurately and changed only when the publication record is verified.